Taxol Receptor Antibodies

Santa Cruz Biotechnology offers a broad range of Taxol Receptor Antibodies for advanced research in cancer biology. Taxol Receptor Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The Taxol receptor, also known as the β-tubulin isotype III, plays a key role in mediating the effects of the chemotherapeutic agent Taxol, which stabilizes microtubules and inhibits cell division. Understanding Taxol receptor function is essential for uncovering mechanisms of drug resistance and enhancing therapeutic strategies in cancer treatment. Research focused on Taxol receptor interactions provides valuable insights into tumor biology and supports the development of more effective cancer therapies. Scientists worldwide rely on Taxol Receptor monoclonal antibodies to explore cellular pathways and molecular mechanisms involved in cancer progression. Advanced research techniques and protocols utilizing Taxol Receptor monoclonal antibodies help reveal new therapeutic targets and potential treatment approaches. Santa Cruz Biotechnology monoclonal antibodies for Taxol Receptor research continue to support breakthrough discoveries in cancer biology and therapeutic development.